Pulling SEC filings + quote and writing the call…

SHERWIN WILLIAMS CO
Next earnings Jul 20, 2026 (before open) · consensus $3.55 EPS, $6.67B rev
Last earnings -3.5% on 2026-04-28
Best-in-class paint compounder with elite ROE and pricing power, but ~31x P/E on a flat-growth, lower-EPS year leaves no cushion.
P/E (price / FY diluted EPS) 31.3 · FY2025
Middling fundamentals and a rich price (~73% above fair value) leave little margin of safety — a wait-and-see.
Sherwin-Williams remains a franchise-quality compounder. The Paint Stores Group — 4,853 stores and growing 80 net last year toward an 80–100 store opening plan for 2026 — drove a 3.2% sales gain almost entirely through pricing (mid-single-digit price increases partially offset by a low-single-digit volume decline), which is the signature of a business with real pricing power. Gross margin expanded to 48.8% from 48.5% as raw-material costs moderated, operating cash flow rose 9.5% to $3.45B (14.6% of sales), and with capex cut 25.5% to $798M the company threw off roughly $2.65B of free cash that funded the Suvinil acquisition, a 9.2% dividend increase to $790M, and buybacks (shares down 1.4%). ROE of 55.9% is elite. This is exactly the kind of durable, cash-generative business you want to own through a cycle.
But the FY2025 numbers also show a business idling. Revenue grew just 2.1% to $23.6B, net income actually fell 4.2% to $2.57B, and reported diluted EPS slipped 2.7% to $10.26 (adjusted EPS was roughly flat at $11.43 vs $11.33). Management is explicit that the 'softer-for-longer demand environment is expected to continue in 2026,' with continued economic pressure on customer buying behavior and Performance Coatings core expected to stay flat. Interest expense is guided up about $85M in 2026 on Suvinil term loans, the new HQ/R&D center, and higher refinancing rates — a direct headwind to EPS. The balance sheet is efficient but stretched: long-term debt climbed 14% to $9.32B, cash is a thin $207M, current liabilities exceed current assets, and retained earnings collapsed 85.8% to $1.03B as capital return outran earnings — the high ROE is partly a leverage artifact.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 18, 2026, 7:22 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $19.9B | $22.1B | $23.1B | $23.1B | $23.6B |
| Gross profit | $8.54B | $9.33B | $10.8B | $11.2B | $11.5B |
| Operating income | $3.08B | $3.40B | $4.16B | — | — |
| Net income | $1.86B | $2.02B | $2.39B | $2.68B | $2.57B |
| Diluted EPS | $6.98 | $7.72 | $9.25 | $10.55 | $10.26 |
| Net margin | 9.3% | 9.1% | 10.4% | 11.6% | 10.9% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
New financing agreement adds direct debt obligation; interest costs set to rise
Q1 2026 10-Q: demand choppiness persists; interest expense climbing in 2026
Q1 2026 10-Q: demand choppiness persists; interest expense climbing in 2026
Disclosed annual shareholder meeting voting results
Entered new financing agreement, creating added direct debt obligation
FY2025: record $23.6B sales, but diluted EPS slipped 2.7% to $10.26
New financing pact adds term debt, tied to funding the Suvinil acquisition
Sources: SEC EDGAR (CIK 0000089800, latest 10-Q filed 2026-04-28) · EODHD · Proprietary analysis · as of 6/18/2026, 11:22:49 PM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-04-06 | Williams Thomas Director | Award | 106.97 @ $315.50 | $33.7K |
| 2026-04-06 | THAMAN MICHAEL H Director | Award | 106.97 @ $315.50 | $33.7K |
| 2026-04-06 | Gamgort Robert James Director | Award | 106.97 @ $315.50 | $33.7K |
| 2026-04-06 | ANDERSON KERRII B Director | Award | 31.70 @ $315.50 | $10.0K |
| 2026-02-24 | Young Bryan J SVP - Corp Strategy & Devel. | Sell | 2.51K @ $364.47 | $916K |
| 2026-02-17 | Young Bryan J SVP - Corp Strategy & Devel. | Award | 3.90K | |
| 2026-02-17 | Young Bryan J SVP - Corp Strategy & Devel. | Tax | 1.39K @ $368.59 | $511K |
| 2026-02-17 | Rea Todd D President, Consumer Brands Grp | Award | 5.10K | |
| 2026-02-17 | Rea Todd D President, Consumer Brands Grp | Tax | 1.88K @ $368.59 | $694K |
| 2026-02-17 | Petz Heidi G President & CEO | Award | 16.8K | |
| 2026-02-17 | Petz Heidi G President & CEO | Tax | 7.49K @ $368.59 | $2.76M |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
2 buys · 1 sell · 1 member · last 180d
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.